• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

中西医结合肝纤维化诊断与治疗指南(2019年版)

Guidelines for diagnosis and treatment of hepatic fibrosis with integrated traditional Chinese and Western medicine (2019 edition).

作者信息

Xu Lie-Ming, Liu Ping

机构信息

Institute of Liver Diseases, Shanghai University of Traditional Chinese Medicine, Shanghai 201203, China.

Institute of Liver Diseases, Shanghai University of Traditional Chinese Medicine, Shanghai 201203, China.

出版信息

J Integr Med. 2020 May;18(3):203-213. doi: 10.1016/j.joim.2020.03.001. Epub 2020 Apr 3.

DOI:10.1016/j.joim.2020.03.001
PMID:32331978
Abstract

In 2006, the Hepatology Committee of Chinese Association of Integrative Medicine issued the "Guidelines for the Prevention and Treatment of Liver Fibrosis with Integrated Traditional Chinese and Western Medicine." In recent years, the fields of Chinese medicine, Western medicine, and integrative medicine have made rapid advances in basic and clinical research into chronic liver disease, and accumulated new evidence for the prevention and treatment of hepatic fibrosis. Therefore, in order to meet clinical needs, liver disease experts of integrated traditional Chinese and Western medicine were united to revise the previous guidelines in order to help physicians make correct and reasonable decisions in the diagnosis and treatment of hepatic fibrosis.

摘要

2006年,中国中西医结合学会肝病专业委员会发布了《肝纤维化中西医结合防治指南》。近年来,中医、西医及中西医结合领域在慢性肝病的基础与临床研究方面取得了快速进展,为肝纤维化的防治积累了新的证据。因此,为满足临床需求,中西医结合肝病专家联合对既往指南进行修订,以帮助医师在肝纤维化的诊疗中做出正确合理的决策。

相似文献

1
Guidelines for diagnosis and treatment of hepatic fibrosis with integrated traditional Chinese and Western medicine (2019 edition).中西医结合肝纤维化诊断与治疗指南(2019年版)
J Integr Med. 2020 May;18(3):203-213. doi: 10.1016/j.joim.2020.03.001. Epub 2020 Apr 3.
2
[Guidelines for the diagnosis and treatment of liver fibrosis with integrated traditional Chinese and Western medicine (2019 edition)].《中西医结合肝纤维化诊断与治疗指南(2019年版)》
Zhonghua Gan Zang Bing Za Zhi. 2019 Jul 20;27(7):494-504. doi: 10.3760/cma.j.issn.1007-3418.2019.07.005.
3
Advances in anti hepatic fibrotic therapy with Traditional Chinese Medicine herbal formula.中药复方抗肝纤维化治疗的研究进展。
J Ethnopharmacol. 2020 Apr 6;251:112442. doi: 10.1016/j.jep.2019.112442. Epub 2019 Dec 28.
4
[Advances in diagnosis and treatment of liver cirrhosis with integrated traditional Chinese and Western medicine].中西医结合治疗肝硬化的诊断与治疗进展
Zhonghua Gan Zang Bing Za Zhi. 2018 May 20;26(5):328-331. doi: 10.3760/cma.j.issn.1007-3418.2018.05.003.
5
Clinical practice guidelines for the treatment of primary liver cancer with integrative traditional Chinese and Western medicine.中西医结合治疗原发性肝癌临床实践指南。
J Integr Med. 2018 Jul;16(4):236-248. doi: 10.1016/j.joim.2018.05.002. Epub 2018 May 17.
6
[Guideline for the diagnosis and treatment of liver fibrosis with integrative medicine].[中西医结合肝纤维化诊疗指南]
Zhongguo Zhong Xi Yi Jie He Za Zhi. 2006 Nov;26(11):1052-6.
7
[Play superior role of integrative medicine thought for further improving clinical efficacy of traditional Chinese medicine against hepatic fibrosis].发挥中西医结合思维的优势作用以进一步提高中医药抗肝纤维化的临床疗效
Zhongguo Zhong Xi Yi Jie He Za Zhi. 2006 Jan;26(1):7-8.
8
[Guideline for the diagnosis and treatment of liver fibrosis with integrative medicine].[中西医结合肝纤维化诊疗指南]
Zhong Xi Yi Jie He Xue Bao. 2006 Nov;4(6):551-5.
9
Angiogenesis and Hepatic Fibrosis: Western and Chinese Medicine Therapies on the Road.血管生成与肝纤维化:中西医结合的治疗之路
Chin J Integr Med. 2018 Sep;24(9):713-720. doi: 10.1007/s11655-018-3007-1. Epub 2018 Jun 25.
10
[Strategies and methods of integrated traditional Chinese and Western medicine in preventing and treating chronic kidney disease].中西医结合防治慢性肾脏病的策略与方法
Zhong Xi Yi Jie He Xue Bao. 2008 May;6(5):449-53. doi: 10.3736/jcim20080503.

引用本文的文献

1
Research and application of medicines for treating liver fibrosis: current status and prospects.治疗肝纤维化药物的研究与应用:现状与展望
Front Pharmacol. 2025 Jul 9;16:1582258. doi: 10.3389/fphar.2025.1582258. eCollection 2025.
2
Mechanistic evaluation of a traditional herbal decoction in attenuating hepatic fibrosis via Nrf2/GPX4 pathway activation and ferroptosis inhibition.一种传统草药汤剂通过激活Nrf2/GPX4通路和抑制铁死亡减轻肝纤维化的机制评估
Hereditas. 2025 Jun 9;162(1):100. doi: 10.1186/s41065-025-00471-y.
3
2-Dodecyl-6-methoxycyclohexa-2,5-dien-1,4-dione alleviates liver fibrosis and improves intestinal flora and bile acid metabolism.
2-十二烷基-6-甲氧基环己-2,5-二烯-1,4-二酮可减轻肝纤维化并改善肠道菌群和胆汁酸代谢。
Front Pharmacol. 2025 May 16;16:1581138. doi: 10.3389/fphar.2025.1581138. eCollection 2025.
4
Diagnostic Value of Serum Cytokeratin 18 for the Staging of Liver Inflammation and Fibrosis: A Meta-Analysis.血清细胞角蛋白18对肝脏炎症和纤维化分期的诊断价值:一项荟萃分析。
J Clin Lab Anal. 2025 Apr;39(8):e70034. doi: 10.1002/jcla.70034. Epub 2025 Apr 9.
5
Integrated evidence chain-based effectiveness evaluation of traditional Chinese medicines (Eff-iEC): A demonstration study.基于整合证据链的中药有效性评价(Eff-iEC):一项示范研究。
Acta Pharm Sin B. 2025 Feb;15(2):909-918. doi: 10.1016/j.apsb.2024.12.024. Epub 2024 Dec 26.
6
Artesunate: A Review of Its Potential Therapeutic Effects and Mechanisms in Digestive Diseases.青蒿琥酯:其在消化系统疾病中的潜在治疗作用及机制综述
Pharmaceutics. 2025 Feb 25;17(3):299. doi: 10.3390/pharmaceutics17030299.
7
Assessing the consistency of FIB-4, APRI, and GPR in evaluating significant liver fibrosis and cirrhosis in COVID-19 patients with concurrent liver diseases.评估FIB-4、APRI和GPR在评估合并肝脏疾病的COVID-19患者显著肝纤维化和肝硬化中的一致性。
BMC Gastroenterol. 2025 Mar 20;25(1):191. doi: 10.1186/s12876-025-03770-w.
8
Inflammation-fibrosis interplay in inflammatory bowel disease: mechanisms, progression, and therapeutic strategies.炎症性肠病中炎症与纤维化的相互作用:机制、进展及治疗策略
Front Pharmacol. 2025 Feb 28;16:1530797. doi: 10.3389/fphar.2025.1530797. eCollection 2025.
9
Effects of Bushen Huayu Decoction combined with entecavir on liver function and hepatic fibrosis in patients with compensated cirrhosis.补肾化瘀汤联合恩替卡韦对代偿期肝硬化患者肝功能及肝纤维化的影响
Am J Transl Res. 2024 Aug 15;16(8):4163-4173. doi: 10.62347/QDXJ3369. eCollection 2024.
10
Yangyinghuoxue decoction exerts a treatment effect on hepatic fibrosis by PI3K/AKT pathway in rat model: based on the network pharmacology and molecular docking.阳营活血汤通过 PI3K/AKT 通路对肝纤维化大鼠模型的治疗作用:基于网络药理学和分子对接。
Aging (Albany NY). 2024 Feb 15;16(4):3773-3789. doi: 10.18632/aging.205559.